Speakers

Expand/Collapse

Science 37
Speaker TBC

Day Two

Thursday, September 9, 2021

9:50 am | Science 37 Presentation

10:20 am | Morning Q&A & Panel Forum

Datacubed Health
Speaker TBC

Day Two

Thursday, September 9, 2021

12:45 pm | Lunchtime Q&A & Panel Forum

John Reites
Chief Executive Officer
THREAD Research

Day One

Wednesday, September 8, 2021

11:20 am | Panel: What Does a Good Decentralized Clinical Trials Look Like?

Ricki Fairley
Chief Executive Officer
TOUCH, The Black Breast Cancer Alliance

Tony Fantana
Lead, Emerging Technology Strategy - Clinical Design, Delivery and Analytics
Eli Lilly and Company

Brendan Mcsheffrey
President
Consent Custody Corporation

Joel Morse
Chief Executive Officer
Curavit

Maria Harrison
Senior Vice President, Decentralized Clinical Trials and Real World Solutions
ICON

Day Two

Thursday, September 9, 2021

10:35 am | Panel: Common Mistakes & Operationalize Recommendations When Deploying Technology Solutions in DCTs

Isaac Rodriguez-Chavez
Senior Vice President of Scientific & Clinical Affairs
ICON

Day One

Wednesday, September 8, 2021

10:25 am | Morning Q&A and Panel Forum

9:50 am | Innovation & High Impact on Patients’ Health Journey: Integrating Decentralized Clinical Trials (DCTs) with Clinical Research as a Care Option (CRAACO)

8:45 am | Chair’s Opening Remarks

Steven R. Cummings
Executive Director, San Francisco Coordinating Center
California Pacific Medical Center Research Institute

Day One

Wednesday, September 8, 2021

5:25 pm | Chair’s Closing Remarks

3:05 pm | Afternoon Q&A Panel Forum

2:10 pm | Removing Complexity: The Art of Cutting Tethers to the Trial Site

Amir Lahav
Digital Healthcare Innovation, Head of Digital R&D
Mitsubishi Tanabe Pharma Holding America

Day Two

Thursday, September 9, 2021

3:25 pm | Panel: Too Hybrid, or Not to Hybridize?

10:35 am | Panel: Common Mistakes & Operationalize Recommendations When Deploying Technology Solutions in DCTs

10:20 am | Morning Q&A & Panel Forum

9:00 am | Keynote: New Trends in Remote Digital Monitoring Technology for Decentralized Trials in Patients with Neurodegenerative Diseases

8:50 am | Chair’s Opening Remarks

Tracey Robertson
Global Clinical Development & Operations – Head of Patient & Site Engagement Process
Boehringer Ingelheim

Day One

Wednesday, September 8, 2021

5:05 pm | Closing Q&A & Panel Forum

4:40 pm | Designing a Hybrid Trial to Support Patient Choice

11:20 am | Panel: What Does a Good Decentralized Clinical Trials Look Like?

Day Two

Thursday, September 9, 2021

4:10 pm | Chair’s Closing Remarks

10:35 am | Panel: Common Mistakes & Operationalize Recommendations When Deploying Technology Solutions in DCTs

Rachel Chasse
Director of Innovation
Digital Medicine Society (DiMe)

Day One

Wednesday, September 8, 2021

10:25 am | Morning Q&A and Panel Forum

9:25 am | DiMe on DCTs: Your How-To Guide

Daniel R Karlin, MD, MA
Chief Medical Officer
MindMed

Day Two

Thursday, September 9, 2021

3:25 pm | Panel: Too Hybrid, or Not to Hybridize?

3:10 pm | Afternoon Q&A & Panel Forum

1:55 pm | DCTs as Agile Clinical Experiments to Develop Novel Methods

Arturo Loaiza-Bonilla
Enterprise Director of Research
Cancer Treatment Centers of America

Day One

Wednesday, September 8, 2021

5:05 pm | Closing Q&A & Panel Forum

4:15 pm | Best Strategies to Optimize Patient Enrolment & Health Care Provider Engagement in the Digital Era: A Case Study

Mary C. Birmingham, PharmD
Director, Clinical Scientist
Janssen Scientific Affairs LLC

Day One

Wednesday, September 8, 2021

11:20 am | Panel: What Does a Good Decentralized Clinical Trials Look Like?

10:25 am | Morning Q&A and Panel Forum

9:00 am | Execution of a Randomized Decentralized Clinical Trial - a J&J Case Study

Rebecca Jackson
Clinical R&D SME - Clinical Data IT, Clinical Trials, Clinical Supply Chain
Johnson & Johnson

Day Two

Thursday, September 9, 2021

10:20 am | Morning Q&A & Panel Forum

9:25 am | Exploring the IMI Trials@Home Initiative

Jim Ternyila
Senior Business Relationship Manager - Digital Therapeutics
AstraZeneca

Day Two

Thursday, September 9, 2021

12:45 pm | Lunchtime Q&A & Panel Forum

12:05 pm | Using Vendors: What to Ask Them and What to Look For?

Amy Bohn
Director, DCT Operations DCT Strategy & Implementation
Bayer

Day One

Wednesday, September 8, 2021

1:00 pm | Midday Q&A panel

12:10 pm | Evaluating Clinical Trials for a Decentralized Approach

Day Two

Thursday, September 9, 2021

3:25 pm | Panel: Too Hybrid, or Not to Hybridize?

Erica Lawson
Director, Applied Innovation
Otsuka

Day Two

Thursday, September 9, 2021

10:35 am | Panel: Common Mistakes & Operationalize Recommendations When Deploying Technology Solutions in DCTs

Arthur Combs, MD
President
FutureTech Strategies, Inc.

Day Two

Thursday, September 9, 2021

3:25 pm | Panel: Too Hybrid, or Not to Hybridize?

Craig Lipset
Co-Chair
Decentralized Trials & Research Alliance (DTRA)

Day Two

Thursday, September 9, 2021

3:10 pm | Afternoon Q&A & Panel Forum

2:20 pm | Collaboration to Accelerate the Global Adoption of Decentralized Trials

Jim Hacunda
R&D Digital Strategy Lead
Takeda

Day One

Wednesday, September 8, 2021

3:05 pm | Afternoon Q&A Panel Forum

2:50 pm | Using Systems Modelling to Compare & Contrast Centralized vs Decentralized Clinical Trials

Vera Rulon
Founder and President
Tir Health Advisors

Ruth Schneider, MD
Assistant Professor of Neurology
University of Rochester

Day Two

Thursday, September 9, 2021

3:10 pm | Afternoon Q&A & Panel Forum

2:45 pm | Lessons from Observational, Remote Research Studies in Neurodegenerative Diseases

Gunilla Andrew-Nielsen
Head of Department of Clinical Trials and Special Permissions
Medical Products Agency

Day One

Wednesday, September 8, 2021

5:05 pm | Closing Q&A & Panel Forum

3:25 pm | Case Studies from Running Patient Centric Clinical Trials Supported by Remote & Virtual Elements

Jen Horonjeff
Founder & CEO
Savvy Cooperative

Day One

Wednesday, September 8, 2021

5:05 pm | Closing Q&A & Panel Forum

3:50 pm | Some ‘Savvy’ Solutions to Providing Your Patients with Choice in a Decentralized Clinical Trial

11:20 am | Panel: What Does a Good Decentralized Clinical Trials Look Like?

Brandon Maggio
Director of Digital & Process Optimization
GSK

Day One

Wednesday, September 8, 2021

11:20 am | Panel: What Does a Good Decentralized Clinical Trials Look Like?

Shoibal Datta
Head, R&D Digital Strategy Group, Data Sciences Institute
Takeda

Day Two

Thursday, September 9, 2021

10:35 am | Panel: Common Mistakes & Operationalize Recommendations When Deploying Technology Solutions in DCTs